selling of medicine at higher price

This discussion explores whether a company can legally sell a unique medicine at an extremely high price if they hold the sole formula. The consensus is that this could be considered an unfair trade practice and monopolistic behaviour. Consumers who have evidence of such price gouging may be able to challenge it through the Consumer Disputes Redressal Commission, as it may fall under unfair trade practices and deficiency in service, especially concerning the current pandemic.